Medtronic Prestige Cervical Disc “Not Inferior” To Fusion – FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Medtronic Sofamor Danek's Prestige ST artificial cervical disc should be approved, contingent upon postmarket submission of seven-year follow up data to help ensure long-term durability, FDA's Orthopedic & Rehabilitation Devices Panel recommended Sept. 19
You may also be interested in...
FDA Panel Favors Medtronic’s Bryan Cervical Disc Despite Durability Question
FDA's Orthopedic and Rehabilitation Devices Panel overwhelmingly supported approval of Medtronic Sofamor Danek's Bryan artificial cervical spinal disc, while acknowledging that the device's long-term durability is unknown
FDA Panel Favors Medtronic’s Bryan Cervical Disc Despite Durability Question
FDA's Orthopedic and Rehabilitation Devices Panel overwhelmingly supported approval of Medtronic Sofamor Danek's Bryan artificial cervical spinal disc, while acknowledging that the device's long-term durability is unknown
Medtronic Preps For Upcoming FDA Panel Meetings On Stent, Spinal Disc
Medtronic is preparing for FDA panel reviews of its Bryan cervical spinal disc in July and itsEndeavor stent this fall, the firm announced May 22